Статті в журналах з теми "Drugs Metabolism"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Drugs Metabolism".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Lambie, David G., and Ralph H. Johnson. "Drugs and Folate Metabolism." Drugs 30, no. 2 (August 1985): 145–55. http://dx.doi.org/10.2165/00003495-198530020-00003.
Desouza, Cyrus, Mary Keebler, Dennis B. McNamara, and Vivian Fonseca. "Drugs Affecting Homocysteine Metabolism." Drugs 62, no. 4 (2002): 605–16. http://dx.doi.org/10.2165/00003495-200262040-00005.
Jann, Michael W., Y. W. Francis Lam, Eric C. Gray, and Wen-Ho Chang. "REVERSIBLE METABOLISM OF DRUGS." Drug Metabolism and Drug Interactions 11, no. 1 (January 1994): 1–24. http://dx.doi.org/10.1515/dmdi.1994.11.1.1.
Reiher, Jean. "Metabolism of Antiepileptic Drugs." Journal of Clinical Neurophysiology 2, no. 3 (July 1985): 309. http://dx.doi.org/10.1097/00004691-198507000-00007.
Durrington, P. "Drugs Affecting Lipid Metabolism." International Journal of Cardiology 45, no. 2 (June 1994): 153–54. http://dx.doi.org/10.1016/0167-5273(94)90276-3.
Franceschini, Guido, and Rodolfo Paoletti. "Drugs controlling triglyceride metabolism." Medicinal Research Reviews 13, no. 2 (March 1993): 125–38. http://dx.doi.org/10.1002/med.2610130202.
Ghiselli, Giancarlo, and Marco Maccarana. "Drugs affecting glycosaminoglycan metabolism." Drug Discovery Today 21, no. 7 (July 2016): 1162–69. http://dx.doi.org/10.1016/j.drudis.2016.05.010.
Kostner, G. M. "Drugs affecting lipid metabolism." Chemistry and Physics of Lipids 51, no. 1 (July 1989): 73–74. http://dx.doi.org/10.1016/0009-3084(89)90068-6.
Sitar, Daniel S. "Metabolism of Thioamide Antithyroid Drugs." Drug Metabolism Reviews 22, no. 5 (January 1990): 477–502. http://dx.doi.org/10.3109/03602539008991448.
Kelly, Patrick, and Barry Kahan. "Review: Metabolism of Immunosuppressant Drugs." Current Drug Metabolism 3, no. 3 (June 1, 2002): 275–87. http://dx.doi.org/10.2174/1389200023337630.
Andrade, Chittaranjan. "Drugs That Escape Hepatic Metabolism." Journal of Clinical Psychiatry 73, no. 07 (July 15, 2012): e889-e890. http://dx.doi.org/10.4088/jcp.12f07726.
Le Couteur, D. G., A. J. McLachlan, and R. de Cabo. "Aging, Drugs, and Drug Metabolism." Journals of Gerontology Series A: Biological Sciences and Medical Sciences 67A, no. 2 (July 18, 2011): 137–39. http://dx.doi.org/10.1093/gerona/glr084.
Davis, T. M. E. "Antimalarial drugs and glucose metabolism." British Journal of Clinical Pharmacology 44, no. 1 (July 1997): 1–7. http://dx.doi.org/10.1046/j.1365-2125.1997.00597.x.
Bogliun, G., E. Beghi, V. Crespi, L. Delodovici, and P. D'Amico. "Anticonvulsant drugs and bone metabolism." Acta Neurologica Scandinavica 74, no. 4 (January 29, 2009): 284–88. http://dx.doi.org/10.1111/j.1600-0404.1986.tb03515.x.
Rizos, Christos V. "Antihypertensive drugs and glucose metabolism." World Journal of Cardiology 6, no. 7 (2014): 517. http://dx.doi.org/10.4330/wjc.v6.i7.517.
Eugene Ramsay, R., and B. J. Wilder. "Metabolism of tricyclic anticonvulsant drugs." Epilepsy & Behavior 3, no. 3 (June 2002): S2—S6. http://dx.doi.org/10.1016/s1525-5050(02)00013-6.
Sarti, Federica, Jan Barthelmes, Javed Iqbal, Fabian Hintzen, and Andreas Bernkop-Schnürch. "Intestinal enzymatic metabolism of drugs." Journal of Pharmacy and Pharmacology 63, no. 3 (February 8, 2011): 392–99. http://dx.doi.org/10.1111/j.2042-7158.2010.01224.x.
Rowe, Thomas C., Volkmar Weissig, and Jeffrey W. Lawrence. "Mitochondrial DNA metabolism targeting drugs." Advanced Drug Delivery Reviews 49, no. 1-2 (July 2001): 175–87. http://dx.doi.org/10.1016/s0169-409x(01)00133-8.
Djakovic-Svajcer, Kornelija. "Food and drugs." Medical review 55, no. 1-2 (2002): 5–12. http://dx.doi.org/10.2298/mpns0202005d.
Melent’ev, A. B., and S. S. Kataev. "Metabolism of designer drugs. Piperazine derivatives." Sudebno-meditsinskaya ekspertiza 58, no. 4 (2015): 49. http://dx.doi.org/10.17116/sudmed201558349-55.
Krishna, Devarakonda R., and Ulrich Klotz. "Extrahepatic Metabolism of Drugs in Humans." Clinical Pharmacokinetics 26, no. 2 (February 1994): 144–60. http://dx.doi.org/10.2165/00003088-199426020-00007.
Ruano, J., F. Fuentes, F. Perez-Jimenez, and J. Lopez-Miranda. "Pharmacogenetics of Drugs Influencing Lipidic Metabolism." Current Genomics 6, no. 2 (March 1, 2005): 115–26. http://dx.doi.org/10.2174/1389202053642311.
&NA;. "Zidovudine metabolism inhibited by numerous drugs." Reactions Weekly &NA;, no. 416 (August 1992): 2. http://dx.doi.org/10.2165/00128415-199204160-00001.
Staack, Roland, and Hans Maurer. "Metabolism of Designer Drugs of Abuse." Current Drug Metabolism 6, no. 3 (June 1, 2005): 259–74. http://dx.doi.org/10.2174/1389200054021825.
KOBASHI, Kyoichi, Teruaki AKAO, Masao HATTORI, and Tsuneo NAMBA. "Metabolism of Drugs by Intestinal Bacteria." Bifidobacteria and Microflora 11, no. 1 (1992): 9–23. http://dx.doi.org/10.12938/bifidus1982.11.1_9.
JANCIN, BRUCE. "Older Antiseizure Drugs Boost Statin Metabolism." Internal Medicine News 38, no. 5 (March 2005): 46. http://dx.doi.org/10.1016/s1553-3212(05)70336-8.
Quiney, Jeremy. "Review of drugs affecting lipid metabolism." Clinica Chimica Acta 179, no. 2 (February 1989): 217. http://dx.doi.org/10.1016/0009-8981(89)90176-9.
ICHIHARA, Kazuo. "Ischemic myocardial metabolism and antianginal drugs." Folia Pharmacologica Japonica 88, no. 6 (1986): 403–12. http://dx.doi.org/10.1254/fpj.88.403.
George, Joseph. "Metabolism and interactions of antileprosy drugs." Biochemical Pharmacology 177 (July 2020): 113993. http://dx.doi.org/10.1016/j.bcp.2020.113993.
Theodore, William H. "Antiepileptic Drugs and Cerebral Glucose Metabolism." Epilepsia 29, s2 (August 1988): S48—S55. http://dx.doi.org/10.1111/j.1528-1157.1988.tb05797.x.
Gescher, Andreas, and Michael D. Threadgill. "The metabolism of triazene antitumor drugs." Pharmacology & Therapeutics 32, no. 2 (January 1987): 191–205. http://dx.doi.org/10.1016/0163-7258(87)90059-3.
Kuznetsov, S. G., and S. M. Chigareva. "Metabolism and directed synthesis of drugs." Pharmaceutical Chemistry Journal 23, no. 7 (July 1989): 602–7. http://dx.doi.org/10.1007/bf00764667.
Sulikowski, Tadeusz. "Metabolism of model drugs in the state of experimental cholestasis." Szczecińskie Roczniki Naukowe X, no. 1 (1996): 23–40. http://dx.doi.org/10.3750/stn/srn/t10/z1/02.
&NA;. "Colony-stimulating factors may alter drugs?? metabolism." Inpharma Weekly &NA;, no. 1059 (October 1996): 20. http://dx.doi.org/10.2165/00128413-199610590-00044.
Melent’ev, A. B., and S. S. Kataev. "Metabolism of designer drugs. The fentanyl derivatives." Sudebno-meditsinskaya ekspertiza 58, no. 5 (2015): 39. http://dx.doi.org/10.17116/sudmed201558539-46.
Natesan, Vijayakumar, and Sung-Jin Kim. "Lipid Metabolism, Disorders and Therapeutic Drugs - Review." Biomolecules & Therapeutics 29, no. 6 (November 1, 2021): 596–604. http://dx.doi.org/10.4062/biomolther.2021.122.
Hagberg, Bengt, and Andreas Killander. "ANTICONVULSIVE DRUGS AND DISTURBED FOLIC ACID METABOLISM." Developmental Medicine & Child Neurology 9, no. 5 (November 12, 2008): 647–48. http://dx.doi.org/10.1111/j.1469-8749.1967.tb02342.x.
Luca, K. De, R. E. Masotti, and M. W. Partington. "Altered Calcium Metabolism due to Anticonvulsant Drugs." Developmental Medicine & Child Neurology 14, no. 3 (November 12, 2008): 318–21. http://dx.doi.org/10.1111/j.1469-8749.1972.tb02596.x.
Borusiak, Peter, Thorsten Langer, Marion Heruth, Michael Karenfort, Ulrich Bettendorf, and Andreas CW Jenke. "Antiepileptic Drugs and Bone Metabolism in Children." Journal of Child Neurology 28, no. 2 (May 2012): 176–83. http://dx.doi.org/10.1177/0883073812443005.
Koren, Gideon. "Accelerated Metabolism of Drugs in Late Pregnancy." Therapeutic Drug Monitoring 26, no. 1 (February 2004): 2. http://dx.doi.org/10.1097/00007691-200402000-00002.
Agúndez, José A. G., Cristobalina Mayorga, and Elena García-Martin. "Drug metabolism and hypersensitivity reactions to drugs." Current Opinion in Allergy and Clinical Immunology 15, no. 4 (August 2015): 277–84. http://dx.doi.org/10.1097/aci.0000000000000174.
Moretti, A., A. Gorini, and R. F. Villa. "Affective disorders, antidepressant drugs and brain metabolism." Molecular Psychiatry 8, no. 9 (August 21, 2003): 773–85. http://dx.doi.org/10.1038/sj.mp.4001353.
Packard, C. J. "Effects of drugs on postprandial lipoprotein metabolism." Proceedings of the Nutrition Society 56, no. 2 (July 1997): 745–51. http://dx.doi.org/10.1079/pns19970075.
Hubbard, J. W., K. K. Midha, E. M. Hawes, G. McKAY, S. R. Marder, M. Aravagiri, and E. D. Korchinski. "Metabolism of Phenothiazine and Butyrophenone Antipsychotic Drugs." British Journal of Psychiatry 163, S22 (December 1993): 19–24. http://dx.doi.org/10.1192/s0007125000292556.
Kharazmi, Arsalan. "Antimalarial drugs and human neutrophil oxidative metabolism." Transactions of the Royal Society of Tropical Medicine and Hygiene 80, no. 1 (January 1986): 94–97. http://dx.doi.org/10.1016/0035-9203(86)90205-1.
Goldin, Barry R. "Intestinal Microflora: Metabolism of Drugs and Carcinogens." Annals of Medicine 22, no. 1 (January 1990): 43–48. http://dx.doi.org/10.3109/07853899009147240.
Verrotti, Alberto, Giangennaro Coppola, Pasquale Parisi, Angelika Mohn, and Francesco Chiarelli. "Bone and calcium metabolism and antiepileptic drugs." Clinical Neurology and Neurosurgery 112, no. 1 (January 2010): 1–10. http://dx.doi.org/10.1016/j.clineuro.2009.10.011.
Slørdal, Lars, and Jarle Aarbakke. "Effect of anticancer drugs on drug metabolism." Pharmacology & Therapeutics 35, no. 1-2 (January 1987): 217–26. http://dx.doi.org/10.1016/0163-7258(87)90107-0.
Rubin, R. L. "Neutrophil-mediated metabolism of autoimmunity inducing drugs." European Journal of Pharmacology 183, no. 1 (July 1990): 79–80. http://dx.doi.org/10.1016/0014-2999(90)91335-9.
de Groot, Marcel J. "Designing better drugs: predicting cytochrome P450 metabolism." Drug Discovery Today 11, no. 13-14 (July 2006): 601–6. http://dx.doi.org/10.1016/j.drudis.2006.05.001.